161 related articles for article (PubMed ID: 36070106)
21. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
22. Smad7 gene transfer attenuates angiogenesis in peritoneal dialysis rats.
Peng W; Dou X; Hao W; Zhou Q; Tang R; Nie J; Lan HY; Yu X
Nephrology (Carlton); 2013 Feb; 18(2):138-47. PubMed ID: 23217002
[TBL] [Abstract][Full Text] [Related]
23. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
[TBL] [Abstract][Full Text] [Related]
25. Epigallocatechin gallate suppresses peritoneal fibrosis in mice.
Kitamura M; Nishino T; Obata Y; Furusu A; Hishikawa Y; Koji T; Kohno S
Chem Biol Interact; 2012 Jan; 195(1):95-104. PubMed ID: 22101032
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.
Lai KN; Leung JC; Chan LY; Li FF; Tang SC; Lam MF; Tse KC; Yip TP; Chan TM; Wieslander A; Vlassara H
Clin Exp Immunol; 2004 Dec; 138(3):466-75. PubMed ID: 15544624
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
[TBL] [Abstract][Full Text] [Related]
28. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
29. Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.
Levanon K; Varda-Bloom N; Greenberger S; Barshack I; Goldberg I; Orenstein A; Breitbart E; Shaish A; Harats D
Pathobiology; 2006; 73(3):149-58. PubMed ID: 17085959
[TBL] [Abstract][Full Text] [Related]
30. (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.
Qi X; Yuan Y; Xu K; Zhong H; Zhang Z; Zhai H; Guan G; Yu G
PLoS One; 2015; 10(5):e0125323. PubMed ID: 25944736
[TBL] [Abstract][Full Text] [Related]
31. Effects of recombinant human endostatin on peritoneal angiogenesis in peritoneal dialysis rats.
Zhao ZZ; Cao Y; Liu ZS; Xiao J; Tang L; Wang P; Liang XH
Nephrology (Carlton); 2011 Aug; 16(6):599-606. PubMed ID: 21457400
[TBL] [Abstract][Full Text] [Related]
32. The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation.
Catar R; Witowski J; Wagner P; Annett Schramm I; Kawka E; Philippe A; Dragun D; Jörres A
Kidney Int; 2013 Dec; 84(6):1119-28. PubMed ID: 23760290
[TBL] [Abstract][Full Text] [Related]
33. Endothelin-1 triggers human peritoneal mesothelial cells' proliferation via ERK1/2-Ets-1 signaling pathway and contributes to endothelial cell angiogenesis.
Zhu N; Gu L; Jia J; Wang X; Wang L; Yang M; Yuan W
J Cell Biochem; 2019 Mar; 120(3):3539-3546. PubMed ID: 30485480
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis.
Peng W; Zhou Q; Ao X; Tang R; Xiao Z
Ren Fail; 2013 Aug; 35(7):958-66. PubMed ID: 23859538
[TBL] [Abstract][Full Text] [Related]
36. Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.
Gensberger-Reigl S; Weigel I; Stützer J; Auditore A; Nikolaus T; Pischetsrieder M
Sci Rep; 2022 Mar; 12(1):4268. PubMed ID: 35277529
[TBL] [Abstract][Full Text] [Related]
37. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
Inagi R; Miyata T; Ueda Y; Yoshino A; Nangaku M; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2002 Aug; 62(2):679-87. PubMed ID: 12110033
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory cytokines promote growth of intestinal smooth muscle cells by induced expression of PDGF-Rβ.
Nair DG; Miller KG; Lourenssen SR; Blennerhassett MG
J Cell Mol Med; 2014 Mar; 18(3):444-54. PubMed ID: 24417820
[TBL] [Abstract][Full Text] [Related]
39. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response.
Welten AG; Schalkwijk CG; ter Wee PM; Meijer S; van den Born J; Beelen RJ
Perit Dial Int; 2003; 23(3):213-21. PubMed ID: 12938820
[TBL] [Abstract][Full Text] [Related]
40. Human placenta-derived multipotent mesenchymal stromal cells involved in placental angiogenesis via the PDGF-BB and STAT3 pathways.
Chen CY; Liu SH; Chen CY; Chen PC; Chen CP
Biol Reprod; 2015 Oct; 93(4):103. PubMed ID: 26353894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
